Liver Panel (ALT, AST, GGT, Bilirubin)
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
Number of studies
2
Safety
Requires caution
Time to effects
Not applicable — the liver panel is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
- →Detects liver damage early, before symptoms like jaundice or right upper quadrant pain appear
- →Distinguishing the hepatocellular and cholestatic patterns steers further, more targeted diagnostic workup
- →Enables monitoring of how medications, alcohol, or metabolic disease affect the liver over time
| Test type | A blood panel assessing liver enzymes (ALT, AST, GGT) and bilirubin |
|---|---|
| Level of evidence | Strong — the American College of Gastroenterology guideline defines a standard interpretation framework |
| Target group | People with liver disease risk factors, those on hepatotoxic medications, as part of routine prevention |
| Key parameters | ALT, AST, GGT, total bilirubin, and its direct and indirect fractions |
| Preparation | Usually doesn't require fasting, though it's often combined with other tests that do |
| Status | A standard screening and monitoring test for liver function |
Understand
Overview
The liver panel (once called liver function tests, but more precisely termed liver chemistries in clinical guidelines) is a blood panel comprising alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and bilirubin. It's one of the most commonly ordered screening tests — used both for prevention and when liver disease is suspected, for monitoring drug therapy, or for assessing the impact of alcohol on the body.
The 2017 American College of Gastroenterology guideline highlights a key distinction: hepatocellular injury is marked by a disproportionately large rise in ALT and AST relative to alkaline phosphatase, while cholestatic injury shows the opposite pattern, with a dominant rise in alkaline phosphatase and GGT. In practice, this distinction steers the entire subsequent workup, from viral hepatitis testing to bile duct imaging.
Who can genuinely benefit from this? People with risk factors for liver disease — overweight, diabetes, regular alcohol consumption — as well as patients on medications with potential hepatotoxicity who need periodic monitoring. A single, minor rise in one parameter rarely means serious disease — what matters clinically is the overall pattern of changes, their magnitude, and the trend over time, assessed together with the clinical history.
Mechanism of action
ALT is found mainly in hepatocyte cytoplasm and is considered a more liver-specific marker of injury, whereas AST is also present in skeletal muscle, the heart, the kidneys, and red blood cells, making it less specific but useful for differentiating causes — for example, an AST-to-ALT ratio above 2 suggests alcohol-related liver injury, while a rise in both enzymes above 1000 IU/L usually points to acute drug-induced injury, viral hepatitis, ischemia, or autoimmune hepatitis. GGT is a membrane-bound enzyme strongly induced by alcohol and certain medications, used mainly to confirm the hepatic origin of an elevated alkaline phosphatase and as a sensitive, though nonspecific, marker of alcohol intake.
Bilirubin is formed mainly from the breakdown of hemoglobin in the reticuloendothelial system as unconjugated (indirect) bilirubin, then transported to the liver, where it's conjugated with glucuronic acid and excreted into bile as conjugated (direct) bilirubin. An elevated direct bilirubin usually points to liver damage or bile duct obstruction, while an isolated rise in indirect bilirubin more often stems from increased hemolysis or a benign, inherited conjugation disorder such as Gilbert syndrome.
Release of ALT and AST from hepatocytes
Damage to the hepatocyte cell membrane causes intracellular enzymes to leak into the blood; ALT is more liver-specific, while AST is also found in muscle, the heart, and the kidneys.
GGT as a marker of cholestasis and alcohol intake
A membrane-bound enzyme induced by alcohol and certain medications, useful for confirming the hepatic origin of an elevated alkaline phosphatase.
Bilirubin conjugation and excretion
Indirect bilirubin forms from hemoglobin breakdown, gets conjugated with glucuronic acid in the liver, and is excreted in bile; an elevated direct bilirubin points to liver damage or bile duct obstruction.
Evidence: strong — based on 2 studies in this database.
Benefits
Common myths
MythAn elevated ALT always means serious liver disease.
FactA mild, transient rise in ALT can stem from intense physical exertion, a recent infection, or certain medications — what indicates liver disease is a persistent pattern of change assessed in a clinical context.
MythGGT only reflects alcohol consumption.
FactGGT is also elevated in nonalcoholic fatty liver disease, cholestasis, or with certain medications — GGT alone doesn't establish the cause.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Usually not, though the lab may recommend fasting if the liver panel is ordered together with other tests, like a lipid panel or glucose, that do require it.
It may indicate enzyme induction from alcohol or medications, early cholestasis, or fatty liver — an isolated GGT elevation rarely requires urgent action, but it's worth discussing with a doctor.
Not always — in the early stages of some conditions, including cirrhosis, liver enzymes can remain within the normal range despite significant organ damage, which is why imaging and additional markers are used when clinical suspicion is high.
What to combine with
Good combinations
Lipid Panel — Elevated ALT combined with an abnormal lipid panel and waist circumference often points to nonalcoholic fatty liver disease as part of metabolic syndrome
Creatinine and eGFR (Estimated Glomerular Filtration Rate) — Assessing liver and kidney function together gives a fuller picture of drug metabolism and overall health
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Intense physical exertion and certain medications (e.g., statins, high-dose acetaminophen) can temporarily raise ALT and AST
Alcohol intake in the days before the test can significantly raise GGT independent of chronic liver disease
Obesity and insulin resistance are associated with chronically elevated ALT in nonalcoholic fatty liver disease
Is it worth taking?
Who it's for
- People with liver disease risk factors such as obesity, diabetes, or regular alcohol consumption
- Patients on medications with potential hepatotoxicity who need periodic liver monitoring
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
ALT is more liver-specific than AST, which is also found in muscle, the heart, and the kidneys.
A rise in ALT or AST above 1000 IU/L suggests acute drug-induced injury, viral hepatitis, ischemia, or autoimmune hepatitis.
Studies
Hepatocellular injury is defined as a disproportionate rise in ALT and AST relative to alkaline phosphatase, while cholestatic injury is defined as a disproportionate rise in alkaline phosphatase relative to ALT and AST.
Kwo PY, Cohen SM, Lim JK, The American Journal of Gastroenterology, 2017
Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study
Strong evidenceCeriotti F, Henny J, Queraltó J, et al. · Clinical Chemistry and Laboratory Medicine · 2010
An international IFCC multicenter study establishing common reference intervals for ALT, AST, and GGT, accounting for differences between populations and sexes.
View studyACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
Strong evidenceKwo PY, Cohen SM, Lim JK · The American Journal of Gastroenterology · 2017
American College of Gastroenterology guideline defining the hepatocellular and cholestatic patterns and the diagnostic algorithm for abnormal liver chemistries.
View studySources & bibliography
- Ceriotti et al. 2010 — Clinical Chemistry and Laboratory Medicine
- Kwo, Cohen, Lim 2017 — ACG Clinical Guideline, Am J Gastroenterol
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
Redakcja VitMode — Hormony i endokrynologiaEditorial team
VitMode Editorial — Hormones and Endocrinology is the VitMode editorial team responsible for: hormones, testosterone therapy, the thyroid and metabolism. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
328 publications on this site
Editorial review
Redakcja VitMode — Badania i biomarkeryEditorial team
VitMode Editorial — Lab Tests and Biomarkers is the VitMode editorial team responsible for: laboratory tests, interpreting results and ageing biomarkers. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
272 publications on this site
Related entries
How to Read a Basic Blood Test Panel
CBC, lipid panel, glucose, TSH — how to read the results of a basic blood panel so you catch early signals of a problem before it becomes a disease.
Lipid Panel
The lipid panel is one of the most important — and still one of the most frequently misread — preventive blood tests: 'total cholesterol' alone tells you less than the ratios between its fractions.
Metabolic Syndrome
A cluster of five risk factors — from abdominal obesity to elevated triglycerides — that multiplies the risk of type 2 diabetes and cardiovascular disease, but is largely modifiable through lifestyle change.
Complete Blood Count (CBC)
The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.
Creatinine and eGFR (Estimated Glomerular Filtration Rate)
Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.
TSH and Thyroid Hormones (fT3, fT4, anti-TPO)
TSH is the first-line test for evaluating thyroid function, but on its own it rarely gives the full picture — only together with fT4, fT3, and anti-TPO can it distinguish a temporary fluctuation from an actual disorder.
Electrolytes: Sodium, Potassium, and Chloride
Sodium, potassium, and chloride sound like a chemistry-class topic, but their blood levels determine how your heart, muscles, and kidneys function — and even a small deviation can be an urgent warning sign.
Uric Acid (Blood Test)
Uric acid is the end product of purine breakdown — its blood test helps assess the risk of gout and kidney stones, but a single result on its own neither confirms nor rules out disease.
Related articles
PoradnikiHigh ALT Without Drinking Alcohol: Causes
A liver panel comes back with elevated ALT, and the person who got it doesn't drink alcohol, or drinks very rarely. This isn't a paradox — alcohol is just one of many possible causes of elevated ALT, and in the general population, not even the most common one. We explain what actually tends to be behind this result, why an intense workout the day before can also skew it, and when it's worth going further.
October 3, 2026
PoradnikiCan Leg Training Raise AST More Than ALT?
Heavy leg training can raise AST noticeably more than ALT — and that's not a coincidence. AST is abundant in skeletal muscle; ALT is far more liver-specific. We explain the mechanism and how to tell this apart from a real liver problem.
September 27, 2026
PoradnikiCan Heavy Training Raise ALT Without Liver Disease?
Yes, very intense, unaccustomed training can raise ALT to values that look like real liver disease — even though the liver is completely healthy. We explain why this happens, who is most affected, and how to tell it apart.
September 27, 2026
PoradnikiNonalcoholic Fatty Liver Disease (NAFLD/MASLD): Overview, Diagnosis, and Treatment
Nonalcoholic fatty liver disease, now increasingly called MASLD, affects roughly a third of the world's adult population according to recent meta-analyses — yet most people don't know they have it, since the disease is typically silent for years. We explain how it's diagnosed, why it progresses to more serious liver inflammation (NASH/MASH) in some patients, and why weight loss remains the first-line treatment.
September 21, 2026
PoradnikiIbuprofen and Alcohol: Can You Mix Them and What Is the Risk?
Ibuprofen and alcohol do not trigger a dangerous chemical reaction, but both irritate the stomach lining and both can burden the kidneys. The best available data come from a case-control study of 1,224 people with upper gastrointestinal bleeding: regular ibuprofen use was linked to a risk about 2.7 times higher, while occasional use showed no significant increase. We explain what this means for someone who fancies a glass of wine and a tablet for a headache, who should avoid the combination altogether, and what science does not yet know.
November 3, 2026
PoradnikiParacetamol (Acetaminophen): Maximum Daily Dose, the Liver and Alcohol
Paracetamol is often regarded as a safe drug, but the line between a therapeutic and a toxic dose is narrower than for many other popular medicines. According to the NIH information page, the maximum dose for adults from all sources combined is 4,000 mg a day, and in a randomised trial in healthy adults taking exactly 4 g a day, ALT activity exceeded three times the upper limit of normal in 31-44% of people. We explain the mechanism of liver injury (NAPQI and glutathione), what is really known about alcohol, why a staggered overdose is dangerous, and in which combination products paracetamol hides.
November 3, 2026
PoradnikiAbdominal Ultrasound: Preparation, Do You Need to Fast and a Full Bladder
Almost every unit asks you to arrive fasting for an abdominal ultrasound, yet the evidence for this advice is surprisingly thin. A 2026 meta-analysis found that fasting does not improve the overall diagnostic sufficiency of the scan; the benefit was limited to the gallbladder and the common bile duct, and a randomised trial of 215 patients found no difference in image quality after breakfast and when fasting. We explain where the advice comes from, when a full bladder is really needed, whether simethicone does anything, and what an ultrasound can and cannot show.
November 3, 2026
PoradnikiHigh Vitamin B12 in a Blood Test: Causes (Not Only Supplements) and When It Is Worrying
A high vitamin B12 result most often just means supplements or cobalamin injections — but not always. In a small share of tests it is a signal of liver or kidney disease, a blood-forming disorder, and in population studies also of a higher chance of a cancer diagnosis in the following months. Sometimes the result is simply wrong because of an assay artefact called macro-B12. We explain how to read the numbers (pg/mL and pmol/L), where to start looking for the cause and when a high B12 needs nothing more than calm.
October 26, 2026